Topoisomerase I Inhibitors in the Treatment of Primary CNS Malignancies: An Update on Recent Trends

E-ISSN： 1875-5992|10|9|683-696

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.10, Iss.9, 2010-01, pp. : 683-696

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Update on Aurora Kinase Inhibitors in Gynecologic Malignancies

Recent Patents on Anti-Cancer Drug Discovery, Vol. 3, Iss. 3, 2008-11 ,pp. : 162-177

Bentham Science Publishers

Access to resources Recommend Favorite

Topoisomerase I Inhibitors and Other New Cytotoxic Drugs

By Verweij J.

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 828-830

Elsevier

Access to resources Recommend Favorite

Topoisomerase I and II Inhibitors: A Patent Review

Recent Patents on Anti-Cancer Drug Discovery, Vol. 11, Iss. 4, 2016-11 ,pp. : 401-423

Bentham Science Publishers

Access to resources Recommend Favorite

Small Molecule Tyrosine Kinase Inhibitors in the Treatment of Solid Tumors: An Update of Recent Developments

By Steeghs Neeltje Nortier Johan Gelderblom Hans

Annals of Surgical Oncology, Vol. 14, Iss. 2, 2007-02 ,pp. : 942-953

Springer Publishing Company

Access to resources Recommend Favorite

DNA-Topoisomerase I, a new target for the treatment of neuroblastoma

By Vassal G. Pondarre C. Cappelli C. Terrier-Lacombe M.J. Boland I. Morizet J. Benard J. Venuat A.M. Ardouin P. Hartmann O. Gouyette A.

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 2011-2015

Elsevier

Access to resources Recommend Favorite